Abstract:ABSTRACT Although gut microbiota alteration and related blood microbe profiles in human immunodeficiency virus (HIV)-infected individuals are associated with the disease progression, how abnormal blood microbe profiles influence the inflammation and immune restoration are not fully understood. To address these issues, this study enrolled 24 healthy controls (HCs) and 91 HIV-infected individuals, including 30 treatment-naïve individuals (TNs), 31 immunological non-responders (INRs), and 30 immunological responders (IRs); subsequently, we analyzed blood microbe profiles using metagenomic sequencing and Olink proteomics technology, and identify inflammation-related proteins in peripheral blood samples of these individuals. The results showed increased translocation of microbes in the blood of TNs. This translocation did not return to normal level in either IRs or INRs who received antiretroviral therapy. In addition, Porphyromonas gingivalis significantly increased in TNs, IRs, and INRs compared to HCs. P. gingivalis was inversely associated with CD4 + T-cell counts, CD4/CD8 ratio, latency-associated peptide transforming growth factor-β1, and tumor necrosis factor-related activation-induced cytokine (TRANCE) and positively associated with HIV reservoirs. Burkholderia multivorans and Bacillus thuringiensis significantly decreased in TNs, IRs, and INRs compared to HCs and were positively associated with CD4 + T-cell counts and the CD4/CD8 ratio and negatively associated with HIV reservoir size and pro-inflammatory factors. We identified several species of microbes that were associated with CD4 + T-cell restoration on antiretroviral therapy, Prevotella sp . CAG:5226, Eubacterium sp . CAG:251, Phascolarctobacterium succinatutens, Anaerobutyricum hallii, Prevotella sp . AM34-19LB, and Phocaeicola plebeius were positively associated with HIV reservoir size and pro-inflammatory proteins. Another group of bacteria, B. multivorans, B. thuringiensis, Vibrio vulnificus, and Acinetobacter baumannii , which were negatively associated and pro-inflammatory proteins. In conclusion, different microbes within blood of HIV-infected individuals were found to be closely associated with persistent inflammation and immune restoration, suggesting the blood microbe profiles of HIV-infected individuals also influence disease progression. IMPORTANCE The characteristics of blood microbiota in HIV-infected individuals and their relevance to disease progression are still unknown, despite alterations in gut microbiota diversity and composition in HIV-infected individuals. Here, we present evidence of increased blood microbiota diversity in HIV-infected individuals, which may result from gut microbiota translocation. Also, we identify a group of microbes, Porphyromonas gingivalis , Prevotella sp. CAG:5226 , Eubacterium sp. CAG:251 , Phascolarctobacterium succinatutens , Anaerobutyricum hallii , Prevotella sp. AM34-19LB , and Phocaeicola plebeius , which are linked to poor immunological recovery. This work provides a scientific foundation toward therapeutic strategies targeting blood microbiota for immune recovery of HIV infection.

The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients

Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: an Observational Study in A Chinese Population

Analysis of the gut microbiota and fecal metabolites in people living with HIV

Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4+ T cell reduction and immune activation

Alterations in the Gut Microbiota of Patients with Acquired Immune Deficiency Syndrome

Systems Analysis of Gut Microbiome Influence on Metabolic Disease in HIV-Positive and High-Risk Populations

A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects

Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals

Abnormal blood microbiota profiles are associated with inflammation and immune restoration in HIV/AIDS individuals

Altered gut microbiome composition in HIV infection: causes, effects and potential intervention

Gut microbiome dysbiosis in men who have sex with men increases HIV infection risk through immunity homeostasis alteration

Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation

Gut dysbiosis associates with cytokine production capacity in viral-suppressed people living with HIV

Integrated analysis of gut and oral microbiome in men who have sex with men with HIV Infection

Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism

Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection

Molecular Characterization of Stool Microbiota in HIV-infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rdna) Quantification and Correlations with Immune Activation.

Causal relationships between gut microbiota, plasma metabolites, and HIV infection: insights from Mendelian randomization and mediation analysis

Alteration of Gut microbiota during HIV infection

The Gut and the Translocated Microbiomes in HIV Infection: Current Concepts and Future Avenues